CYCLOPHARM LIMITED

1.92%

$1.02

Market Cap $113.3M

Technology Scientific & Technical Instruments

Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's... Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

CYC Medicine

CYC - Daily General Banter & US Rollout

11/06/25

6.1K

11/06/25

Last post Pozzo23

6.1K

CYC

Ann: Cyclopharm Secures Maximum US Patent Extension for Technegas

11/06/25

272

11/06/25

Last post

ASX News

272

CYC

05/06/25

843

05/06/25

Last post RDude

843

CYC

Ann: Results of AGM

30/05/25

199

30/05/25

Last post

ASX News

199

CYC

Ann: CYC 2025 AGM Presentation

30/05/25

1.0K

30/05/25

Last post ben286812

1.0K

CYC

Ann: Managing Director's Address to Shareholders

30/05/25

220

30/05/25

Last post

ASX News

220

CYC

Ann: Chair's Address to Shareholders

30/05/25

143

30/05/25

Last post

ASX News

143

CYC

Ann: Technegas Installed at First DoD Hospital

26/05/25

4.1K

26/05/25

Last post asx11

4.1K

See All Discussions

Timeline

Cyclopharm Secures Maximum US Patent Extension for Technegas
11 Jun 08:19	Share

Results of AGM
30 May 14:08	Share

CYC 2025 AGM Presentation
30 May 10:17	Share

Managing Director's Address to Shareholders
30 May 10:16	Share

Chair's Address to Shareholders
30 May 10:15	Share

Notice of Annual General Meeting/Proxy Form
29 Apr 16:20	Share

Technegas Installed at First DoD Hospital
10 Apr 10:46	Share

Revised Date of Annual General Meeting
09 Apr 10:19	Share

Technegas US Momentum Accelerates with $US1m Sales Milestone
01 Apr 09:51	Share

Appendix 4G & Corporate Governance Statement
27 Mar 14:11	Share

Annual Report to shareholders
27 Mar 14:11	Share

CYC to present at NWR Virtual Healthcare Conference
19 Mar 14:53	Share

Company Update
19 Mar 10:12	Share

Webinar - Cyclopharm Business Update
17 Mar 10:56	Share

CYC signs 5-year Agreement with USA Veterans Administration
14 Mar 08:20	Share

Date of Annual General Meeting
10 Mar 16:03	Share

Change of Director's Interest Notice - DH
26 Feb 13:38	Share

Change of Director's Interest Notice - JW
26 Feb 13:02	Share

CYC Results Summary
25 Feb 08:03	Share

Preliminary Final Report
25 Feb 08:02	Share

Change in substantial shareholding from AEF
28 Jan 14:44	Share

CYC Signs US National Agreement with HCA for Technegas
23 Jan 08:19	Share

Response to ASX Price Query
06 Jan 15:27	Share

Cyclopharm's USA Technegas Expansion Update
20 Dec 11:06	Share

US Clinical Paper - Technegas for Lung Transplant Evaluation
09 Dec 08:59	Share

First Patients Imaged with Technegas - French Clinical Trial
03 Dec 08:30	Share

CYC Receives First Technegas Orders from US VA Hospitals
27 Nov 15:03	Share

Cyclopharm Bell Potter Healthcare Conference Presentation
19 Nov 08:29	Share

CYC Signs Agreement with VA and First DoD Order Received
03 Oct 10:07	Share

Change of Director's Interest Notice - JW
01 Oct 15:43	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.02		Change -0.020(1.92%)		Mkt cap ! $113.3M

Open	High	Low	Value	Volume
$1.04	$1.05	$1.02	$220.9K	213.0K

Buyers (Bids)

No.	Vol.	Price($)
1	9803	$1.01

Sellers (Offers)

Price($)	Vol.	No.
$1.02	49222	1

View Market Depth

No.	Vol.	Price($)
1	9803	1.010
4	34700	1.000
1	30000	0.990
1	10000	0.980
1	1031	0.970

Price($)	Vol.	No.
1.080	32047	1
1.110	1980	2
1.115	2150	1
1.135	490	1
1.140	14998	1

Last trade - 16.10pm 13/06/2025 (20 minute delay)

CYC (ASX) Chart

CYCLOPHARM LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

Cyclopharm doses first French patients with technegas in PRONOSPECT trial

Cyclopharm (ASX:CYC) has revealed its dosed its first French patients with its technegas lung imaging product in an ongoing trial.

Cyclopharm wins US FDA approval for Technegas

Cyclopharm (ASX:CYC) has received approval from the United States FDA to commence commercial sales of its novel drug candidate, Technegas.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

CYCLOPHARM LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

Cyclopharm doses first French patients with technegas in PRONOSPECT trial

Cyclopharm (ASX:CYC) has revealed its dosed its first French patients with its technegas lung imaging product in an ongoing trial.

Cyclopharm wins US FDA approval for Technegas

Cyclopharm (ASX:CYC) has received approval from the United States FDA to commence commercial sales of its novel drug candidate, Technegas.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available